» Articles » PMID: 39442072

The Impact of Undetected Hyperglycaemia During Pregnancy on Maternal and Neonatal Outcomes

Overview
Journal J Mother Child
Publisher Sciendo
Date 2024 Oct 23
PMID 39442072
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite clear diagnostic criteria for hyperglycaemia first detected in pregnancy, many pregnant women do not have the proper diagnosis. The following paper analyses the course of the perinatal period in pregnant women with undetected hyperglycaemia and their newborns.

Materials And Methods: Medical data of patients hospitalized in the Department of Perinatology between 2020 and 2022 was verified: 1st group: 40 patients with undetected hyperglycaemia, 2nd group: 40 with the diagnosis of gestational diabetes during pregnancy and adequate therapeutic management. The course of the perinatal period, abnormalities in the oral glucose tolerance test (OGTT) and the compliance with recommended postpartum tests were analysed.

Results: There were significant differences in the newborn weights (p=0.039) - in the 1st group 15% large for gestational age (LGA) vs. 0% in the 2nd, and the occurrence of neonatal hyperbilirubinemia requiring phototherapy (p=0.007) - 22.5% in the 1 group vs. 2.5% in the 2. The most common mistake in the OGTT was evaluation of fasting plasma glucose. In the 1 group, no effect on incidence of hypertensive disorders, time or the route of delivery was observed. 75% from the 1 group and 36% from the 2 did not perform postpartum OGTT (p=0.003).

Conclusion: Hyperglycaemia in pregnancy is often undetected, which has a negative impact, especially on the neonates. In our study, LGA and hyperbilirubinaemia were significantly more common in neonates of mothers with undetected hyperglycaemia. These women had significantly more careless attitude to the postpartum diagnostic, which may influence future health and course of subsequent pregnancies. New and more effective methods of educating practitioners need to be implemented.

References
1.
Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

2.
Korvesi V, Chouvarda I, Mastorakos G, Goulis D . Implementation of the Endocrine Society clinical practice guidelines for gestational diabetes mellitus to a knowledge tool. Eur J Clin Invest. 2020; 50(9):e13291. DOI: 10.1111/eci.13291. View

3.
Babu G, Tejaswi B, Kalavathi M, Vatsala G, Murthy G, Kinra S . Assessment of screening practices for gestational hyperglycaemia in public health facilities: a descriptive study in bangalore, India. J Public Health Res. 2015; 4(1):448. PMC: 4407043. DOI: 10.4081/jphr.2015.448. View

4.
He J, Song J, Zou Z, Fan X, Tian R, Xu J . Association between neonatal hyperbilirubinemia and hypoglycemia in Chinese women with diabetes in pregnancy and influence factors. Sci Rep. 2022; 12(1):16975. PMC: 9550859. DOI: 10.1038/s41598-022-21114-6. View

5.
Imoh L, Longwap A, Haruna F, Asieba O, Istifanus J, Imoh J . Practices and barriers to screening for hyperglycaemia in pregnancy among providers of antenatal care in Jos, Nigeria. Afr J Lab Med. 2022; 11(1):1845. PMC: 9634787. DOI: 10.4102/ajlm.v11i1.1845. View